Background
==========

Primary aldosteronism (PA) is the most common cause of endocrine hypertension ([@bib1]). It is related to significant cardiovascular morbidity and should be diagnosed and treated promptly ([@bib1]). Appropriate treatment of PA depends upon the correct classification: whether it is unilateral or bilateral aldosterone hypersecretion ([@bib2]). The usage of CT in defining aetiology of PA is controversial and, due to a rather high prevalence of adrenal incidentaloma in general population, it can be misleading in many patients ([@bib3], [@bib4]). The gold standard for establishing the aetiology of PA is adrenal vein sampling (AVS) ([@bib2]). However, AVS is expensive, technically demanding and its availability is therefore quite limited ([@bib4]). Nevertheless, due to the lack of availability of AVS, diagnosis and further treatment decisions for patients with PA are sometimes based on the results of the CT scan ([@bib3]).

In this article, we present two cases of discrepant results of CT imaging and AVS which demonstrate that CT is not a reliable method for localising the source of excess aldosterone production.

Case 1
======

Case presentation
-----------------

A 59-year-old male was referred to the emergency department for severe headache. His personal history was uneventful, except for arterial hypertension over the last 5 years. Recently, the blood pressure was inadequately controlled, despite the continuous therapy with the combination of indapamide and ramipril. His BMI was 30 kg/m^2^ and blood pressure was 195/115 mmHg. He had no renal bruits and no signs of the Cushing's syndrome. A laboratory analysis showed marked hypokalaemia of 2.4 mmol/L.

Investigation
-------------

Ambulatory 24-h BP monitoring revealed \>82% of readings above normal. A hormonal workup, performed after antihypertensive treatment was stopped for 2 weeks, showed increased aldosterone-to-renin ratio (ARR) without aldosterone suppression in the saline infusion test (SIT; 2 L of intravenous 0.9% saline over 4 h). Adrenal CT demonstrated a 13 mm hypodense nodule in the left adrenal gland, whereas the right adrenal gland appeared normal ([Fig. 1](#fig1){ref-type="fig"}). In contrast, AVS demonstrated aldosterone hypersecretion in the right gland with the lateralisation index of 13.1 and the contralateral suppression index of 0.05 ([Table 1](#tbl1){ref-type="table"}). Figure 1Case 1. Coronal (A) and axial (B) nonenhanced CT scan of the abdomen showing tumour on the left adrenal gland (white arrow). Right adrenal gland is without abnormalities (black arrow). Table 1Hormonal workup in case 1.ValuesAldosterone (pmol/L)Cortisol (nmol/L)A/CParameters at diagnosis of PA PRA (µg/L/h)0.1 (0.2--2.8) PAC (pmol/L)1267 (20--410) ARR457 (\<30) Post SIT PAC (pmol/L)1060 (\<277)AVS results Left adrenal vein486034,9600.13 Right adrenal vein4210023,0401.82 Inferior vena cava242010362.33 Lateralisation index13.1 Contralateral suppression Index0.05Follow-up (3 months after surgery) Post SIT PAC (pmol/L)83 Potassium (mmol/L)4.1 Average BP (mmHg)128/80[^1][^2]

Treatment, outcome and follow-up
--------------------------------

Laparoscopic adrenalectomy of the right adrenal gland was performed and histology was consistent with small adrenocortical adenoma. Follow-up evaluation, performed 3 months after the surgery, revealed a well-controlled BP (without any antihypertensive treatment), a normal potassium level and adequate aldosterone suppression after SIT ([Table 1](#tbl1){ref-type="table"}).

Case 2
======

Case presentation
-----------------

A 62-year-old female was referred for the evaluation of hypokalaemia (serum potassium concentration: 2.0 mmol/L) that was discovered during a workup for acute cholecystitis. Her BMI was 27.8 kg/m^2^ and blood pressure was 180/100 mmHg. Her personal history revealed arterial hypertension, diagnosed at the age of 38 years and gallstones. She has been taking valsartan and lercanidipine, which were discontinued 2 weeks prior to hormonal evaluation.

Investigation
-------------

Raised ARR with no PAC (plasma aldosterone concentration) suppression after the saline infusion test led to the diagnosis of PA. CT demonstrated a 19 mm nodule in the left adrenal gland ([Fig. 2](#fig2){ref-type="fig"}), whereas AVS lateralised aldosterone hypersecretion in the right adrenal gland ([Table 2](#tbl2){ref-type="table"}). Figure 2Case 2. Coronal (A) and axial (B and C) contrast-enhanced CT scan of the abdomen showing tumour on the left adrenal gland (white arrow). Right adrenal gland is without abnormalities (black arrow). Table 2Hormonal workup in case 2.ValuesAldosterone (pmol/L)Cortisol (nmol/L)A/CParameters at diagnosis of PA PRA (µg/L/h)0.1 (0.2--2.8) PAC (pmol/L)947 (20--410) ARR341 (\<30) Post SIT PAC (pmol/L)516 (\<277)AVS results Left adrenal vein356447240.75 Right adrenal vein73,12815,5004.7 Inferior vena cava10815222.07 Lateralisation index6.25 Contralateral suppression Index0.36Follow-up (3 months after surgery) Post SIT PAC (pmol/L)20 Potassium (mmol/L)4.3 Average BP (mmHg)132/78[^3][^4]

Treatment, outcome and follow-up
--------------------------------

Laparoscopic adrenalectomy of the right adrenal gland was performed and histology was consistent with small adrenocortical adenoma. A follow-up evaluation performed 3 months after the surgery confirmed remission of the disease with normal serum potassium concentration and well-controlled blood pressure with one antihypertensive drug (lercanidipine) ([Table 2](#tbl2){ref-type="table"}).

Discussion
==========

PA represents an autonomous aldosterone hypersecretion that can originate from one or both adrenal glands. In 60% of cases, the underlying aetiology of PA is bilateral adrenal hyperplasia (BAH). In 35% of cases, it is aldosterone-producing adenoma (APA), whereas other causes, such as unilateral adrenal hyperplasia and aldosterone-producing adrenocortical carcinoma, account for about 5% of patients ([@bib1], [@bib2]). However, from the clinical point of view, it is crucial to separate bilateral from unilateral aldosterone hypersecretion as the treatment of the two differs significantly.

According to current guidelines, AVS is the gold standard test for establishing the aetiology of PA with sensitivity and specificity of 95 and 100%, respectively ([@bib2]). However, AVS is an expensive, invasive, complex procedure, without standardised criteria and available only in a limited number of specialised centres ([@bib3], [@bib4]). Therefore, young patients (aged \<35 years) with spontaneous hypokalaemia, marked aldosterone excess and unilateral adrenal mass, may not need AVS before proceeding to unilateral adrenalectomy ([@bib2]).

CT represents another option for determining the source of aldosterone excess, but its overall accuracy in defining PA aetiology is less than 60% ([@bib5], [@bib6]) due to the fact that some aldosteronomas are small tumours which might not be detected on CT scans. Moreover, due to a large prevalence of adrenal incidentaloma among the general population, a nonfunctional incidentaloma can be easily misdiagnosed for APA ([@bib5]).

Many authors, in order to distinguish BAH from APA, have developed scoring systems based on the combination of clinical, biochemical and radiological parameters ([@bib6], [@bib7]). In accordance with said systems, the non-peformance of AVS may be considered in patients scoring results suggestive of BAH ([@bib7]). Nevertheless, in patients with unilateral disease, the scoring system does not provide the information on the side of the affected gland. Accordingly, both of our patients would have been appropriately diagnosed with unilateral disease, but surgical treatment based on the CT scan would have resulted in the removal of the unaffected adrenal gland.

The necessity to perform AVS was also questioned in the SPARTACUS trial ([@bib8]), which was the first randomised diagnostic trial in this clinical area. The study consisted of PA patients randomly assigned to undergo either CT or AVS in order to define the PA subtype and associated treatment. Follow-up was performed after 1 year and no significant difference was found in the clinical outcome between the two groups; the CT-based treatment was equally effective as the AVS-based treatment in terms of antihypertensive medication and health-related quality of life ([@bib8]).

Nevertheless, the validity of the study results was quite limited by significant selection bias and a rather inappropriate choice of the primary endpoint for this type of study ([@bib9]). Furthermore, regarding the biochemical remission of the disease, there was a trend in favour of AVS (80% biochemical remission in the CT versus 89% in the AVS group) ([@bib8]). It is possible that, with a sufficient number of patients, that trend would have reached significance. A recently published large retrospective study comparing the diagnostic value of CT and AVS for unilateral PA reported favourable biochemical outcomes of adrenalectomy in PA patients whose surgical management was based on AVS ([@bib10]). They concluded how patients diagnosed only by CT had a decreased likelihood of achieving complete biochemical success post surgery ([@bib10]).

In this article, we presented two patients with PA caused by unilateral disease. In both cases, CT showed a tumour on the left side, whereas AVS lateralised aldosterone hypersecretion on the opposite side. These two patients demonstrate that even in the case of a high probability of unilateral disease, identification of the adrenal gland responsible for the aldosterone hypersecretion should be based exclusively on the results of AVS.
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[^1]: AVS was performed under continuous infusion of cosyntropine and with sequential sampling. Lateralisation index = aldosterone/cortisole~dominant\ adrenal\ vein~/aldosterone/cortisole~non-dominant\ adrenal\ vein~. Lateralisation index \>4 was used for defining lateralisation of aldosterone excess. Contralateral suppression index = aldosterone/cortisol~non-dominant\ adrenal\ vein~/aldosterone/cortisole~inf.vena\ cava~.

[^2]: PRA (plasma renin activity). PAC (plasma aldosterone concentration). Post SIT PAC (post saline infusion test PAC) \>277 pmol/L was used as a criterion for the diagnosis of PA.

[^3]: AVS was performed under continuos infusion of cosyntropine and with sequential sampling. Lateralisation index = aldosterone/cortisole~dominant\ adrenal\ vein~/aldosterone/cortisole~non-dominant\ adrenal\ vein~. Lateralisation index \>4 was used for defining lateralisation of aldosterone excess. Contralateral suppression index = aldosterone/cortisol~non-dominant\ adrenal\ vein~/aldosterone/cortisole~inf.vena\ cava~.

[^4]: PRA (plasma renin activity). PAC (plasma aldosterone concentration). Post SIT PAC (post saline infusion test PAC) \>277 pmol/L was used as a criterion for the diagnosis of PA.
